Endometrial Carcinoma Treatment Advances

Expert gynecologic oncologist Brian Slomovitz, MD, MS, FACOG, shares insight on novel therapeutic approaches to the management of endometrial cancer.

EP. 1: An Overview of Endometrial Cancer and Treatment Options

January 14th 2022

Expert perspectives on the endometrial cancer treatment landscape in light of approved therapies and drug classes.

EP. 2: Treating a Patient at Endometrial Cancer Relapse

January 14th 2022

Brian Slomovitz, MD, MS, FACOG, provides a brief review of endometrial cancer relapse and corresponding therapeutic approaches.

EP. 3: Combination of I/O and TKI Therapy in Endometrial Cancer

January 14th 2022

Insight on the combination of lenvatinib and pembrolizumab in endometrial cancer, investigated between the KEYNOTE-146 and KEYNOTE-775 trials.

EP. 4: Lenvatinib + Pembrolizumab in Endometrial Cancer: Practical Considerations

January 14th 2022

Practical perspectives on the optimal use of combination lenvatinib-pembrolizumab in endometrial cancer.

EP. 5: Novel Strategies Being Investigated in Endometrial Cancer

January 14th 2022

Brian Slomovitz, MD, MS, FACOG, shares excitement for novel and combination therapies being investigated in the endometrial cancer landscape.

EP. 6: Looking Toward the Future of Endometrial Cancer Management

January 14th 2022

Reflections on the future management of endometrial cancer and practical advice for practicing oncologists.